Computed tomography of experimental liver abscesses using a new liposomal contrast agent

Investigative Radiology

Volumn 31, Issue 4, 1996, Pages 194-203

  Dick, Armin ^a   Adam, Gerhard ^a   Tacke, Josef ^a   Prescher, Andreas ^a   Southon, Timothy E ^b   Günther, Rolf W ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b NYCOMED IMAGING AS   (Norway)

Author keywords

computed tomography; Liposomal contrast agent; liver abscess model

Indexed keywords

CONTRAST MEDIUM; IODIXANOL; IOPENTOL; LIPOSOME;

ABDOMINAL AORTA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; IMAGE QUALITY; INFERIOR CAVA VEIN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER ABSCESS; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RABBIT;

EID: 0029922111     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199604000-00003     Document Type: Article

References (36)

1. Halvorsen RA Jr, Foster WL Jr, Wilkinson RH Jr, Silverman PM, Thompson WM. Hepatic abscesses: Sensitivity of imaging tests and clinical findings. Gastrointest Radiol 1988;13:135-141.
2. Ralls PW, Barnes PF, Radin DR, Colletti P, Halls J. Sonographic features of amebic and pyogenic liver abscesses: A blinded comparison. AJR Am J Roentgenol 1987;149:499-501.
3. Rails PW, Henley DS, Colletti PM, et al. Amebic liver abscesses: MR imaging. Radiology 1987;165:801-804.
4. Eliozondo G, Weissleder R, Stark DD, et al. Amebic liver abscesses: Diagnosis and treatment evaluation with MR imaging. Radiology 1987;165:795-800.
5. Yamashita Y, Hatanaka Y, Yamamoto H, et al. Differential diagnosis of focal liver lesions: Role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology 1994;193:59-65.
6. Leander P. A new liposomal contrast medium for computed tomography of the liver. Acta Radiol. In press.
7. Leander P, Månsson S, Ege T, Besjakov J. CT and MR imaging of the liver using liver-specific contrast media: A comparative study in a tumor model. Acta Radiol. In press.
8. Skinnemoen K. Physikochemical properties and degree of protein binding of lopentol. Acta Radiol Suppl. 1987;370:33-36.
9. Leunbach I, Skinnemoen K, Golman K. Metabolism and excretion of Iopentol in the pig. Acta Radiol Suppl. 1987;370:105-107.
10. Heywood R, Mayfield R, Allan JA, Michelet AA. Summary of the toxicologie profile of iopentol. Acta Radiol Suppl. 1987;37:45-48.
11. Adam G, Günther RW, Schiffer C, Görtz H, Prescher A, Scherer K. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluoroctylbromide emulsion. Influence of dosage and injection velocity in an animal model. Invest Radiol 1992;27:698-705.
12. Bernardino ME, Erwin BC, Steinberg HV, et al. Delayed hepatic CT scanning: Increased confidence and improved detection of hepatic metastases. Radiology 1986;159:71-74.
13. Miller DL, Simmons JT, Chang R, Ward BA, et al. Hepatic metastasis detection: Comparison of three CT contrast enhancement methods. Radiology 1987;165:785-790.
14. Young SW, Enzmann DR, Long DM, Muller HH. Perfluoroctylbromide contrast enhancement of malignant neoplasms: Preliminary observations. AJR Am J Roentgenol 1981;137:141-146.
15. Mattrey RF, Long DM, Multer FK, Mitten RM, Higgins CB. Perfluoroctylbromide: A reticuloendothelial-specific and tumor-imaging agent for computed tomography. Radiology 1982;145: 755-758.
16. Mattrey RF, Long DM, Peck WW, Slutsky RA, Higgins CB. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography. J Comput Assist Tomogr 1984;8:739-744.
17. Grimes G, Vermess M, Gallel JF, Girton M, Chatterji DC. Formulation and evaluation of ethiodized oil emulsion for intravenous hepatography. J Pharm Sci 1979;68:52-56.
18. Thomas JL, Bernardino ME, Vermess M, et al. EOE-13 in the detection of hepatosplenic lymphoma. Radiology 1982;145:629-634.
19. Cassel DM, Young SW, Brody WR, Muller HH, Hall AL. Radiographic blood pool contrast agents for vascular and tumor imaging with projection radiography and computed tomography. J Comput Assist Tomogr 1982;6:141-146.
20. Doucet D, Meyer D, Chambon C, Bonnemain B. Blood-pool x-ray contrast agents: Evaluation of a new iodinated polymer. Invest Radiol 1991;26:53-54.
21. Revel D, Chambon C, Havard P, et al. Iodinated polymer as bloodpool contrast agent: Computed tomography evaluation in rabbits. Invest Radiol 1991;26:57-59.
22. Bruneton JN, Falewee MN, Balu-Maestro C, Normand F, Mattrey RF. Perfluoroctylbromide and hepatosplenic computed tomography: A preliminary clinical study. Invest Radiol 1988; 23(suppl 1):306-307.
23. Mattrey RF, Strich G, Shelton RE, et al. Perfluorchemicals as ultrasound contrast agents for tumor imaging and hepatosplenography: Preliminary clinical results. Radiology 1987;163:339-443.
24. Tremper KK, Freidman AE, Levine EM, Lapin R, Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 1982;307:277-283.
25. Vermess M, Doppman JL, Sugarbaker PH, et al. Computed tomography of the liver and spleen with intravenous lipoid contrast material: Review of 60 examinations. AJR Am J Roentgenol 1982;138:1063-1071.
26. Miller DL, Rosenbaum RC, Sugarbaker PH, Vermess M, Willis M, Doppman JL. Detection of hepatic metastases: Comparison of EOE-13 computed tomography and scintigraphy. AJR Am J Roentgenol 1983;141:931-935.
27. Miller DL, Vermess M, Doppman JL, et al. CT of the liver and spleen with EOE-13: Review of 225 examinations. AJR Am J Roentgenol 1984;143:235-243.
28. Sugarbaker PH, Vermess M, Doppman JL, Miller DL, Simon R. Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion 13 (EOE-13) liver contrast. Cancer 1984;54:1489-1495.
29. Seltzer SE, Blau M, Herman LW, et al. Contrast material-carrying liposomes: Biodistribution, clearance, and imaging characteristics. Radiology 1995;194:775-781.
30. Sachse A, Leike JU, Rößling GL, et al. Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection. Invest Radiol 1993;28:838-844.
31. Trubetskoy VS, Cannilo JA, Milshein A, et al. Controlled delivery of Gd-containing liposomes to lymph nodes: Surface modification may enhance MRI contrast properties. Magn Reson Imaging 1994;13:31-37.
32. Mattrey RF, Andre M, Campbell J, et al. Specific enhancement of intraabdominal abscesses with perfluoroctylbromide for CT imaging. Invest Radiol 1984;19:438-446.
33. Mattrey RF. Blood-pool contrast media are the ideal agents for computed tomography. Invest Radiol 1991;26:55-56.
34. Mattrey RF, Brown JJ, Shelton RE, Ogino MT, Johnson KK, Mitten RM. Use of perfluoroctylbromide (PFOB) to detect liver abscesses with computed tomography: Safety and efficacy. Invest Radiol 1991;26:792-798.
35. Mattrey RF. Potential role of perfluoroctylbromide in the detection and characterization of liver lesions with CT. Radiology 1989;170:18-20.
36. Patronas N, Miller DL, Girton M. Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases. Invest Radiol 1984;19:570-573.